Study title |
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis (QUASAR) |
Disease or condition |
Ulcerative colitis |
Study type |
Interventional (Clinical Trial) |
Intervention/treatment |
Guselkumab or Ustekinumab or Placebo |
Phase |
2b/3 |
Study site |
University of North Carolina |
Study location |
Chapel Hill |
Principal investigator |
Animesh Jain ibdtrials@med.unc.edu |
Study coordinator |
Emily English emily_english@med.unc.edu |
Phone contact |
919-843-8105 |
Clinicaltrials.gov link |
https://clinicaltrials.gov/ct2/show/NCT04033445 |